Upgrade to SI Premium - Free Trial

Unusual 11 Mid-Day Movers 12/23: (ADMS) (MEMP) (SXE) Higher; (NWBO) (GBSN) (STEM) Lower

December 23, 2015 1:01 PM
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) 51.8% HIGHER; announced that its Phase 3 EASE LID clinical trial evaluating the company’s investigational ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles